Zurich Cantonal Bank’s Denali Therapeutics DNLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$610K Buy
43,587
+3,830
+10% +$53.6K ﹤0.01% 1533
2025
Q1
$540K Hold
39,757
﹤0.01% 1556
2024
Q4
$810K Buy
39,757
+10,038
+34% +$205K ﹤0.01% 1322
2024
Q3
$866K Buy
29,719
+3,316
+13% +$96.6K ﹤0.01% 1201
2024
Q2
$613K Buy
26,403
+1,372
+5% +$31.9K ﹤0.01% 1354
2024
Q1
$514K Buy
25,031
+2,244
+10% +$46K ﹤0.01% 1446
2023
Q4
$489K Buy
22,787
+2,108
+10% +$45.2K ﹤0.01% 1514
2023
Q3
$427K Buy
20,679
+2,124
+11% +$43.8K ﹤0.01% 1492
2023
Q2
$548K Buy
18,555
+1,737
+10% +$51.3K ﹤0.01% 1294
2023
Q1
$387K Buy
16,818
+4,500
+37% +$104K ﹤0.01% 1445
2022
Q4
$343K Buy
12,318
+810
+7% +$22.5K ﹤0.01% 1482
2022
Q3
$353K Hold
11,508
﹤0.01% 1406
2022
Q2
$339K Buy
11,508
+118
+1% +$3.48K ﹤0.01% 1476
2022
Q1
$366K Buy
11,390
+446
+4% +$14.3K ﹤0.01% 1529
2021
Q4
$488K Buy
10,944
+2,118
+24% +$94.4K ﹤0.01% 1456
2021
Q3
$445K Sell
8,826
-11
-0.1% -$555 ﹤0.01% 1377
2021
Q2
$693K Sell
8,837
-446
-5% -$35K ﹤0.01% 1038
2021
Q1
$530K Buy
9,283
+77
+0.8% +$4.4K ﹤0.01% 1185
2020
Q4
$771K Buy
9,206
+632
+7% +$52.9K ﹤0.01% 1066
2020
Q3
$307K Hold
8,574
﹤0.01% 1325
2020
Q2
$207K Buy
8,574
+2,386
+39% +$57.6K ﹤0.01% 1492
2020
Q1
$108K Buy
6,188
+2,740
+79% +$47.8K ﹤0.01% 1565
2019
Q4
$60K Sell
3,448
-1,541
-31% -$26.8K ﹤0.01% 2041
2019
Q3
$76K Hold
4,989
﹤0.01% 1762
2019
Q2
$104K Sell
4,989
-4,759
-49% -$99.2K ﹤0.01% 1595
2019
Q1
$226K Sell
9,748
-688
-7% -$16K ﹤0.01% 1140
2018
Q4
$216K Buy
10,436
+1,237
+13% +$25.6K ﹤0.01% 1166
2018
Q3
$200K Buy
9,199
+1,999
+28% +$43.5K ﹤0.01% 1304
2018
Q2
$110K Hold
7,200
﹤0.01% 1589
2018
Q1
$142K Buy
+7,200
New +$142K ﹤0.01% 1404